Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
CONCLUSIONS: In studies of adults with CKD G5D treated with dialysis, sevelamer may lower death (all causes) compared to calcium-based binders and incur less treatment-related hypercalcaemia, while we found no clinically important benefits of any phosphate binder on cardiovascular death, myocardial infarction, stroke, fracture or coronary artery calcification. The effects of binders on patient-important outcomes compared to placebo are uncertain. In patients with CKD G2 to G5, the effects of sevelamer, lanthanum, and iron-based phosphate binders on cardiovascular, vascular calcification, and bone outcomes compared to placebo or usual care, are also uncertain and they may incur constipation, while iron-based binders may lead to diarrhoea. PMID: 30132304 [PubMed - as supplied by publisher]
We present a rare case of hemichorea associated with a hemorrhagic stroke in the contralateral striatum.
The geriatric population is at high risk of severe low blood glucose (LBG) events due to diminished homeostatic mechanisms, especially on hypoglycemic medications. Moderate to severe LBG events in these patients can contribute to behavior changes such as agitation, change in level of consciousness, disruption of sleep, instability and increased risk of myocardial infarction, stroke and falls. Rapid recognition and appropriate treatment and prevention of LBG and recurrences can reduce risk for hospitalization in the geriatric population.
More News: Calcium | Cardiology | Cardiovascular | Chronic Kidney Disease | Clinical Trials | Conferences | Constipation | Databases & Libraries | Dialysis | Diarrhoea | General Medicine | Heart | Heart Attack | Hemodialysis | Hormones | Hypercalcaemia | Iron | Kidney Transplant | Kidney Transplantation | Magnesium | Orthopaedics | Peritoneal Dialysis | Stroke | Study | Transplant Surgery | Transplants | Urology & Nephrology